Neurodegeneration and glutamate induced oxidative stress

Progress in Brain Research

Volumn 116, Issue , 1998, Pages 245-263

  Nakao, N ^a   Brundin, P ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

2 [[4 [2,6 BIS(1 PYRROLIDINYL) 4 PYRIMIDINYL] 1 PIPERAZINYL]METHYL] 3,4 DIHYDRO 2,5,7,8 TETRAMETHYL 2H 1 BENZOPYRAN 6 OL; ALPHA TOCOPHEROL; AMPA RECEPTOR; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; GLUTAMIC ACID; KAINIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N TERT BUTYL ALPHA PHENYLNITRONE; QUINOLINIC ACID; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; APOPTOSIS; BASAL GANGLION; BRAIN ISCHEMIA; BRAIN MITOCHONDRION; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CONTROLLED STUDY; CORPUS STRIATUM; HUNTINGTON CHOREA; MITOCHONDRIAL ENERGY TRANSFER; NERVE CELL NECROSIS; NERVE DEGENERATION; NEUROPROTECTION; NEUROTRANSMITTER RELEASE; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; RECEPTOR INTRINSIC ACTIVITY; REVIEW; SUBSTANTIA NIGRA;

EID: 0031764481     PISSN: 00796123     EISSN: None     Source Type: Book Series    
DOI: 10.1016/s0079-6123(08)60441-0     Document Type: Review

References (121)

1. Y. Agid F. Javoy-Agid M. Ruberg Biochemistry of neurotransmitter in Parkinson's disease C.D. Marsden S. Fahn Movement Disorder Vol 2 1987 Butterworths London 166 230
2. P.K. Andrus T.J. Fleck J.A. Oostveen E.D. Hall Neuroprotective effects of the novel brain-penetrating pyrrolopyrimidine antioxidants U-101033E and U-104067F against post-ischemic degeneration of nigrostriatal neurons J., Neurosci. Res. 47 1997 650 654
3. M. Ankarcrona J.M. Dypbukt E. Bonfoco B. Zhivotovsky S. Orrenius S.A. Lipton P. Nicotera Glutamate-induced neuronal death: A succession of necrosis and apoptosis depending on mitochondrial function Neuron 15 1995 961 973
4. C. Atabay C.M. Cagnoli E. Kharlamov M.D. Ikonomovic H. Manev Removal of serum from primary cultures of cerebellar granule neurons induces oxidative stress and DNA fragmentation: Protection with antioxidants and glutamate receptor antagonists J. Neurosci. Res. 43 1996 465 475
5. R. Auer T. Wieloch Y. Olsson Siesjö B.K. The distribution of hypoglycemic brain damage Acta Neuropathol. 64 1984 117 191
6. M.H.M. Bakker A.C. Foster An investigation of the time mechanisms of delayed neurodegeneration caused by direct injection of quinolinate into the rat striatum Neuroscience 42 1991 387 395
7. A. Bast P.R. Bär The antioxidant/prooxidant balance in neurodegeneration and neuroprotection P.R. Bär M.F. Beal Neuroprotection in CNS diseases 1997 Marcel Dekker Inc. 147 160
8. M.F. Beal N.W. Kowall D.W. Ellison M.F. Mazurek K.J. Swartz J.B. Martin Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid Nature 321 1986 168 171
9. M.F. Beal N.W. Kowal K.J. Swartz R.J. Ferrnante J.B. Martin Systemic approaches to modifying quinolinic acid striatal lesions in rats J. Neurosci. 8 1988 3901 3908
10. M.F. Beal W.R. Matson K. Swartz P.H. Gamache E.D. Bird Kynurenine pathway measurements in Huntington's disease striatum: Evidence for reduced formation of kynurenic acid J. Neurochem. 55 1990 1327 1339
11. M.F. Beal B.T. Hyman W. Koroshetz Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases Trends Neurosci. 16 1993 125 131
12. M.F. Beal E. Brouillet B.G. Jenkins R.J. Ferrante N.W. Kowall J.M. Miller E. Storey R. Srivastava B.R. Rosen B.T. Hyman Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid J. Neurosci. 13 1993 4148 4192
13. M.F. Beal E. Brouillet B.G. Jenkins R. Henshaw B.R. Rosen B.T. Hyman Age-dependent striatal excitotoxic lesions produced by the endogenous mitochondrial inhibitor malonate J. Neurochem. 61 1993 1147 1154
14. J.S. Beckmann T.W. Beckman J. Chen P.A. Marshall B.A. Freeman Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide Proc. Natl. Acad. Sci. USA 87 1990 1620 1624
15. E.D. Bird Chemical pathology of Huntington's disease Annu. Rev. Pharmacol. Toxicol. 20 1980 533 551
16. M.P. Blaustein Calcium transport and buffering in neurons Trends Neurosci. 11 1988 438 443
17. R.J. Boegman Y. Smith A. Parent Quinolinic acid does not spare striatal neuropeptide Y-immunoreactive neurons Brain Res. 415 1987 178 182
18. J.P. Bolanos S.J.R. Heales J.M. Land J.B. Clark Effect of peroxynitrite on the mitochondrial respiratory chain: Differential susceptibility of neurones and astrocytes in primary culture J. Neurochem. 64 1995 1965 1972
19. E. Brouillet B.G. Jenkins B.T. Hyman R.J. Ferrante N.W. Kowall R. Srivastava D.S. Roy B.R. Rosen M.F. Beal Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid J. Neurochem. 60 1993 356 359
20. S.L. Budd D.G. Nicholls Mitochondria, calcium regulation, and acute glutamate excitotoxicity in cultured cerebellar granule cells J. Neurochem. 67 1996 2282 2291
21. X. Cao J.W. Phillis α-Phenyl- tert -butyl-nitrone reduces cortical infarct and edema in rats subjected to focal ischemia Brain Res. 644 1994 267 272
22. E. Carafoli Calcium pump of the plasma membrane Physiol. Rev. 71 1991 129 153
23. J.M. Carney P.E. Starke-Reed C.N. Oliver R.W. Landum M.S. Cheng J.F. Wu R.A. Floyd Reversal of age-related increase in brain oxidation, decrease in enzyme activity, and loss in temporal and spatial memory by chronic administration of the spin-trapping compound N-tert -butyl-α-phenylnitrone Proc. Natl. Acad. Sci. USA 88 1991 3636 3666
24. P.H. Chan L. Chu S.F. Chen E.J. Carlson C.J. Epstein Reduced glutamate neurotoxicity in transgenic mice expressing human Cu-Zn superoxide dismutase Stroke 21 1990 80 82
25. Y.J. Chen B.G. Jenkins B.R. Rosen Evidence of impairment of energy metabolism in Parkinson's disease using in vivo localized MR spectroscopy Proc. Soc. Magn. Res. 1 1994 194
26. G. Cheng M. Griffin J.L. Poyer P.B. McCay HPLC procedure for the pharmacokinetics study of the spintrapping agent, α-phenyl- n -nitrone (PBN) Free Rad. Biol. Med. 8 1993 93 98
27. Y. Cheng Sun A.Y. Oxidative mechanisms involved in kainate-induced cytotoxicity in cortical neurons Neurochem. Res. 12 1994 1557 1564
28. D.W. Choi Ionic dependence of glutamate neurotoxicity J. Neurosci. 7 1987 369 379
29. G. Cohen R. Farooqui N. Kesler Parkinson's disease: A new link between monoamine oxidase and mitochondrial electron flow Proc. Natl. Acad. Sci. USA 94 1997 4890 4894
30. J.T. Coyle P. Puttfarcken Oxidative stress, glutamate, and neurodegenerative disorders Science 262 1993 689 695
31. J.T. Coyle R. Schwarcz Lesion of striatal neurones with kainic acid provides a model for Huntington's chorea Nature 263 1976 244 246
32. S.W. Davies P.J. Roberts No evidence for preservation of somatostatin-containing neurons after intrastriatal injections of quinolinic acid Nature 327 1987 326 329
33. S.W. Davies M. Turmaine B.A. Cozens M. DiFiglia A.H. Sharp C.A. Ross E. Scherzinger E.E. Wanker L. Mangiarini G. Bates Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation Cell 90 1997 537 546
34. T.M. Dawson V.L. Dawson S.H. Snyder A novel neuronal messenger molecule in brain: The free radical, nitric oxide Ann. Neurol. 32 1992 297 311
35. D.T. Dexter F.R. Wells A.J. Lees F. Javoy-Agid Y. Agid P. Jenner C.D. Marsden Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease J. Neurochem. 52 1989 1830 1836
36. D.T. Dexter C.J. Carter F.R. Wells F. Javoy-Agid Y. Agid A.J. Lees P. Jenner C.D. Marsden Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease J. Neurochem. 52 1989 381 389
37. D.T. Dexter A. Carayon M. Vidailhet M. Ruberg F. Javoy-Agid Y. Agid A.J. Lees F.R. Wells P. Jenner C.D. Marsden Decreased ferritin levels in brain in Parkinson's disease J. Neurochem. 55 1990 16 20
38. J.M. Dubinski B.S. Kristal M. Elizondo-Fournier An obligate role for oxygen in the early stages of glutamate-induced, delayed neuronal death J. Neurosci. 15 1995 7071 7078
39. L.L. Dugan S.L. Sensi L.M.T. Canzoniero S.D. Handran S.M. Rothman T.-S. Lin M.P. Goldberg D.W. Choi Mitochondrial production of reactive oxygen species in cortical neurons following exposure to N -methyl-D-aspartate J. Neurosci. 15 1995 6377 6388
40. L.L. Dugan D.M. Turetsky C. Du D. Lobner M. Wheeler C.R. Almli C.K.-F. Shen T.-Y. Luh D.W. Choi T.-S. Lin Carboxyfullerenes as neuroprotective agents Proc. Natl. Acad. Sci. USA 94 1997 9434 9439
41. J.A. Dykens A. Stern E. Trencker Mechanism of kainate toxicity to cerebellar neurons in vitro is analogous to reperfusion tissue injury J. Neurochem. 49 1987 1222 1228
42. A. Favit F. Nicoletti U. Scapagnini P.L. Canonico Ubiquinone protects cultured neurons against spontaneous and excitotoxin-induced degeneration J. Cereb. Blood Flow Metab. 12 1992 638 645
43. R.J. Ferrante N.W. Kowal M.F. Beal E.P. Richardson Jr. E.D. Bird J.B. Martin Selective sparing of a class of striatal neurons in Huntington's disease Science 230 1985 561 563
44. R.J. Ferrante N.W. Kowall P.B. Cipolloni E. Storey M.F. Beal Excitotoxin lesions in primates as a model for Huntington's disease: Histopathologic and neurochemical characterization Exp. Neurol. 119 1993 46 71
45. A. Francis W. Pulsinelli The response of GA-BAergic and cholinergic neurons to transient cerebral ischemia Brain Res. 243 1982 271 278
46. E.M. Frodl N. Nakao P. Brundin Lazaroids improve the survival of cultured rat embryonic mesencephalic neurons Neuroreport 5 1994 2393 2396
47. Y. Glinka M. Gassen M.B.H. Youdim Mechanism of 6-hydroxydoparnine neurotoxicity J. Neural Transm. (Suppl) 50 1997 55 66
48. G.A. Graveland R.S. Williams M. DiFiglia Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington's disease Science 227 1985 770 773
49. P.G. Gunasekar A.G. Kanthasamy J.L. Borowitz G.E. Isom NMDA receptor activation produces concurrent generation of nitric oxide and reactive oxygen species: Implication for cell death J. Neurochem. 65 1995 2016 2021
50. E.D. Hall Lipid antioxidants as neuroprotectants for acute and chronic neurodegenerative disorders P.R. Bär M.F. Beal Neuroprotection in CNS diseases 1997 Marcel Dekker Inc. 161 182
51. B. Halliwell J.M.C. Gutteridge Free Radicals in Biology and Medicine. 1989 Clarendon Press Oxford
52. P.S. Harper Huntington's disease 2nd Ed 1996 W.B. Saunders London 1438
53. R.H. Hatfield R. Gill C. Brazell The dose-response relationship and therapeutic window for dizocilpine (MK-801) in a rat focal ischaemia model Eur. J. Pharmacol. 216 1992 1 7
54. R.E. Heikkila G. Cohen 6-Hydroxydopamine: Evidence for superoxide radical as an oxidative intermediate Science 181 1973 456 457
55. C.W. Heizmann W. Hunziker Intracellular calcium-binding proteins: More site than insights Trends Biochem. Sci. 16 1991 98 103
56. W.F. Holt Glutamate in health and disease: The role of inhibitors P.R. Bär M.F. Beal Neuroprotection in CNS diseases 1997 Marcel Dekker Inc. 87 120
57. K.R. Hoyt I.J. Reynolds T.G. Hastings Mechanisms of dopamine-induced cell death in cultured rat forebrain neurons: Interactions with and differences from glutamate-induced cell death Exp. Neurol. 143 1997 269 281
58. K.R. Hoyt I.J. Reynolds T.G. Hastings A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes Cell 72 1993 971 983 Huntington's Disease Collaborative Research Group
59. K. Jellinger The pathology of parkinsonism C.D. Marsden S. Fahn Movement Disorder Vol 2 1987 Butterworths London 124 165
60. B.G. Jenkins W.J. Koroshetz M.F. Beal B.R. Rosen Evidence for impairment of energy metabolism in vivo in Huntington's disease using localized IH NMR spectros-copy Neurology 43 1993 2689 2695
61. G.V.W. Johnson R.S. Jope The role of microtubule-associated protein 2 (MAP-2) in neuronal growth, plasticity, and degeneration J. Neurosci. Res. 33 1992 505 512
62. M. Lafon-Cazal S. Pietri M. Culcasi J. Bockaert NMDA-dependent superoxide production and neurotoxicity Nature 364 1993 535 537
63. J.W. Langston Mechanisms of MPTP toxicity: More answers, more questions Trends Pharmacol. Sci. 6 1985 375 378
64. M. Leist E. Fava C. Montecucco P. Nicotera Peroxynitrite and nitric oxide donors induce neuronal apoptosis by eliciting autocrine excitotoxicity Eur. J. Neurosci. 9 1997 1488 1498
65. S.A. Lipton P.A. Rosenberg Excitatory amino acids as a final common pathway for neurologic disorders N. Engl. J. Med. 330 1994 613 622
66. M.E. MacDonald J.F. Gusella Huntington's disease: Translating a CAG repeat into a pathogenetic model Curr. Opin. Neurobiol. 6 1996 638 643
67. L. Mangiarini K. Sathasivam M. Seller B. Cozens A. Harper C. Hetherington M. Lawton Y. Trottier H. Lehrach S.W. Davies G.P. Bates Exon 1 of the Huntington's disease gene containing a highly expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice Cell 87 1996 497 506
68. I. Marey-Semper M. Gelman M. Levi-Strauss A selective toxicity toward cultured mesencephalic dopaminergic neurons is induced by the synergistic effects of energetic metabolism impairment and NMDA receptor activation J. Neurosci. 15 1995 5912 5918
69. M. Mayer M. Noble N-acetyl-L-cysteine is a pluripotent protector against cell death and enhancer of trophic factor mediated cell survival in vitro Proc. Natl. Acad. Sci. USA 91 1994 7496 7500
70. E.G. McGeer P.L. McGeer Duplication of biochemical changes of Huntington's chorea by intrastriatal injection of glutamic acid and kainic acids Nature 263 1976 517 519
71. P.L. McGeer S. Itagaki H. Akiyama E.G. McGeer Rate of cell death in parkinsonism indicates active neuropathological process Ann. Neurol. 24 1988 574 576
72. M. Miyamoto T.H. Murphy R.L. Schnaar J.T. Coyle Antioxidants protect against glutamate-induced cytotoxicity in a neuronal cell line J. Pharmacol. Exp. Ther. 260 1989 1132 1140
73. M. Miyamoto J.T. Coyle Idebenone attenuates neuronal degeneration induced by intrastriatal injection of excitotoxins Exp. Neurol. 108 1990 38 45
74. Y. Mizuno S. Ohta M. Tanaka S. Takiyama K. Suzuki T. Sato H. Oya T. Ozawa Y. Kagawa Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease. Biochem Biophys. Res. Commun. 163 1989 1450 1455
75. M. Monyer M.F. Goldberg D.W. Choi Glucose deprivation neuronal injury in cortical cell culture Brain Res. 483 1989 347 354
76. M. Monyer D.M. Hartley D.W. Choi 21-Aminosteroids attenuate excitotoxic neuronal injury in cortical cell cultures Neuron 5 1990 121 126
77. U. Muller J. Krieglstein Prolonged pretreatment with a-lipoic acid protects cultured neurons against hypoxic, glutamate-, or iron-induced injury J. Cereb. Blood Flow Metab. 15 1995 624 630
78. R.H. Myers J.P. Vonsattel T.J. Stevens L.A. Cupples E.P. Richardson J.B. Martin E.D. Bird Clinical and neuropathologic assessment of severity in Huntington's disease Neurology 38 1988 341 347
79. N. Nakao E.M. Grasbon-Frodl H. Widner P. Brundin Antioxidant treatment protects striatal neurons against excitotoxic insults Neuroscience 73 1996 185 200
80. N. Nakao P. Brundin Effects of α-phenyl- tert -butyl nitrone on neuronal survival and motor function following intrastriatal injections of quinolinate or 3-nitropropionic acid Neuroscience 76 1997 749 761
81. R. Nath A.W. Probert K.M. McGinnis K.K.W. Wang Activation of apoptosis-linked ICE related caspase(s) in excitotoxin and hypoxia/hypoglycemia induced neuronal death Soc. Neurosci. Abstr. 567 1997 3
82. P. Nicotera M. Leist Apoptosis and control of cell death P.R. Bär M.F. Beal Neuroprotection in CNS diseases 1997 Marcel Dekker Inc. 319 330
83. A. Novelli J.A. Reilly P.G. Lysko R.C. Henneberry Glutamate becomes neurotoxic via the N -methyl-D-aspartate receptor when intracellular energy levels are reduced Brain Res. 451 1988 205 212
84. R.L. Nussbaum M.H. Polymeropoulos Genetics of Parkinson's disease Human Mol. Genet. 6 1997 1987 1991
85. C.W. Olanow A radical hypothesis for neurodegeneration Trends Neurosci. 16 1993 439 444
86. J.W. Olney Neurotoxicity of excitatory amino acids E.G. McGeer J.W. Olney P.L. McGeer Kainic Acid as A Tool in Neurobiology. 1978 Raven Press New York 95 121
87. J.W. Olney J. Labruyera M.T. Price Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs Science 244 1989 1360 1362
88. L.A.J. O'Neill C. Kaltschmidt NF-kPB: A crucial transcription factor for glial and neuronal cell function Trends Neurosci. 20 1997 252 258
89. S. Orrenius D.J. McConkey G. Bellomo P. Nicotera Role of Ca2+ in toxic cell killing Trends Pharmacol. Sci. 10 1989 281 285
90. C.K. Park D.G. Nehls D.I. Graham G.M. Teasdale J. McCullough Focal cerebral ischaemia in the cat. Treatment with glutamate antagonist MK-801 after induction of ischaemia J. Cereb. Blood Flow Metab. 8 1988 757 762
91. M. Patel B.J. Day J.D. Crapo I. Fridovich J.O. McNamara Requirement for superoxide in excitotoxic cell death Neuron 16 1996 345 355
92. D.E. Pellegrini-Giampietro G. Cherici M. Alesiani V. Carla F. Moroni Excitatory amino acid release and free radical formation may cooperate in the genesis of ischemia-induced neuronal damage J. Neurosci. 10 1990 1035 1041
93. D. Pelligrino Siesjö B.K. Regulation of extra- and intracellular pH in the brain in severe hypoglycemia J. Cereb. Blood Flow Metab. 4 1981 85 96
94. T.L. Perry D.V. Godin S. Hansen Parkinson's disease: A disorder due to nigral glutathione deficiency? Neurosci. Lett. 33 1982 305 310
95. W. Pulsinelli J.B. Brierley F. Plum Temporal profile of neuronal damage in a model transient forebrain ischemia Ann. Neurol. 11 1982 491 498
96. P.S. Puttfarcken R.L. Getz J.T. Coyle Kainic acid-induced lipid peroxidation: Protection with butylated hydroxytoluene and U78517F in primary cultures of cerebellar granule cells Brain Res. 624 1993 223 232
97. A.H. Rajput Clinical features and natural history of Parkinson's disease (special consideration of aging) D.B. Calne Neurodegenerative Diseases. 1994 W.B. Saunders Company Philadelphia 555 571
98. I.J. Reynolds T.G. Hastings Glutamate induces the production of reactive oxygen species in cultured forebrain neurons following NMDA receptor activation J. Neurosci. 15 1995 3318 3327
99. C. Richter J.W. Park B.N. Arnes Normal oxidative damage to mitochondrial and nuclear DNA is extensive Proc. Natl. Acad. Sci. USA 85 1988 6465 6467
100. P. Riederer S. Wuketich Time course of nigrostriatal degeneration in Parkinson's disease J. Neural Transm. 38 1976 277 301
101. A.H.V. Schapira J.M. Cooper D.T. Dexter J.B. Clark P. Jenner C.D. Marsden Mitochondrial complex I deficiency in Parkinson's disease J. Neurochem. 54 1990 823 827
102. J.B. Schulz D.R. Henshaw D. Siwek B.G. Jenkins R.J. Ferrante P.B. Cipolloni N.W. Kowall B.R. Rosen M.F. Beal Involvement of free radicals in excitotoxicity in vivo J. Neurochem. 64 1995 2239 2247
103. J.B. Schulz R.T. Matthews B.G. Jenkins P. Brar M.F. Beal Improved therapeutic window for treatment of histotoxic hypoxia with a free radical spin trap J. Cereb. Blood Flow Metab. 15 1995 948 952
104. R. Schwarcz E. Okuno R.J. White E.D. Bird W.O. Whetsell 3-Hydroxyanthranilate oxygenase activity is increased in the brains of Huntington's disease victims Proc. Natl. Acad. Sci. USA 85 1988 4079 4081
105. R. Schwarcz W.O. Whetsell Jr. R.M. Mangano Quinolinic acid: An endogenous metabolite that produces axon-sparing lesions in rat brain Science 219 1983 316 318
106. S. Sen J.W. Phillis α-phenyl- tert -butyl-nitrone (PBN) attenuates hydroxyl radical production during is-chemia-reperfusion injury of rat brain – an EPR study Free Rad. Res. Commun. 19 1993 255 265
107. A.H. Sharp C.A. Ross Neurobiology of Huntington's disease Neurobiol. Dis. 3 1996 3 15
108. J.P. Sheehan R.H. Swerdlow W.D. Parker S.W. Miller R.E. Davis J.B. Tuttle Altered calcium homeostasis in cells transformed by mitochondria from individuals with Parkinson's disease J. Neurochem. 68 1997 1221 1233
109. Siesjö B.K. Cell damage in the brain: A speculative synthesis J. Cereb. Blood Flow Metab. 1 1981 155 185
110. J.R. Simpson O. Isacson Mitochondrial impairment reduces the threshold for in vivo NMDA-mediated neuronal death in the striatum Exp. Neurol. 121 1993 57 64
111. M.-L. Smith R. Auer Siesjö B. The density and distribution of ischemic brain injury in rat following 2–10 min of forebrain ischemia Acta Neuropathol. 64 1984 319 332
112. E. Storey B.T. Hyman B. Jenkins E. Brouillet J.M. Miller B.R. Rosen M.F. Beal 1-Methyl-4-phenyl-pyridinium produces excitotoxic lesions in rat striatum as a result of impairment of oxidative metabolism J. Neurochem. 58 1992 1975 1978
113. P.K. Stys S.G. Waxman B.R. Ransom Ionic mechanisms of anoxic injury in mammalian CNS white matter: Role of Na+ channels and Na+ -Ca2+ exchanger J. Neurosci. 12 1992 430 439
114. C.E. Thomas Nitrone spin traps as protectants against oxidative damage P.R. Bär M.F. Beal Neuroprotection in CNS diseases 1997 Marcel Dekker, Inc. 183 204
115. T.A. Uhler D.M. Frim P. Pakzaban O. Isacson The effects of megadose methylprednisolone and U-78517F on toxicity mediated by glutamate receptors in the rat neostriatum Neurosurgery 34 1994 122 128
116. J.C. Watson R. Bullock Neuroprotection in acute neurological disease: Trauma to the brain and spinal cord P.R. Bär M.F. Beal Neuroprotection in CNS diseases 1997 Marcel Dekker Inc. 387 408
117. T. Wieloch Hypoglycemia-induced neuronal damage prevented by an N -methyl-D-aspartate antagonist Science 230 1985 681 683
118. T.L. Yue J.-L. Gu P.G. Lysko H.-Y. Cheng F.C. Barone G. Feuerstein Neuroprotective effects of phenyl-t-butyl-nitrone in gerbil global brain ischemia and in cultured rat cerebellar neurons Brain Res. 574 1992 193 197
119. G.D. Zeevalk W.J. Nicklas Chemically induced hypoglycemia and anoxia: Relationship to glutamate receptor-mediated toxicity in retina J. Pharmacol. Exp. Ther. 253 1990 1285 1292
120. G.D. Zeevalk E. Derr-Yellin W.J. Nicklas Relative vulnerability of dopamine and GABA neurons in mesencephalic culture to inhibition of succinate dehydrogenase by malonate and 3-nitropropionic acid and protection by NMDA receptor blockade J. Pharmacol. Exp. Therapeut. 275 1995 1124 1130
121. Q. Zhao K. Pahlmark M.-L. Srnith Siesjö B.K. Delayed treatment with the spin tarp α-phenyl- N-tert -butyl nitrone (PBN) reduces infarct size following transient middle cerebral artery occlusion in rats Acta Physiol. Scand. 152 1994 349 350